Physicochemical Properties and Analytical Method Development for Drug Substance of GML-1, a Novel Original Anxiolytic Preparation
- Authors: Gaevaya L.M.1, Grushevskaya L.N.1, Sergeeva M.S.1, Illarionov A.A.1, Avdyunina N.I.1, Pyatin B.M.1, Baiburtskii F.S.1, Mokrov G.V.1
- 
							Affiliations: 
							- Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
 
- Issue: Vol 52, No 9 (2018)
- Pages: 790-795
- Section: Structure of Chemical Compounds, Method of Analysis and Process Control
- URL: https://ogarev-online.ru/0091-150X/article/view/245467
- DOI: https://doi.org/10.1007/s11094-018-1901-7
- ID: 245467
Cite item
Abstract
The physicochemical properties of the novel original anxiolytic GML-1 drug substance were studied, analytical techniques for it were developed, and its main pharmacopoeial quality parameters were determined using IR spectroscopy, UV spectrophotometry, HPLC, and the Kjeldahl method.
Keywords
About the authors
L. M. Gaevaya
Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
							Author for correspondence.
							Email: otopharm@mail.ru
				                					                																			                												                	Russian Federation, 							Moscow, 125315						
L. N. Grushevskaya
Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
														Email: otopharm@mail.ru
				                					                																			                												                	Russian Federation, 							Moscow, 125315						
M. S. Sergeeva
Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
														Email: otopharm@mail.ru
				                					                																			                												                	Russian Federation, 							Moscow, 125315						
A. A. Illarionov
Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
														Email: otopharm@mail.ru
				                					                																			                												                	Russian Federation, 							Moscow, 125315						
N. I. Avdyunina
Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
														Email: otopharm@mail.ru
				                					                																			                												                	Russian Federation, 							Moscow, 125315						
B. M. Pyatin
Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
														Email: otopharm@mail.ru
				                					                																			                												                	Russian Federation, 							Moscow, 125315						
F. S. Baiburtskii
Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
														Email: otopharm@mail.ru
				                					                																			                												                	Russian Federation, 							Moscow, 125315						
G. V. Mokrov
Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
														Email: otopharm@mail.ru
				                					                																			                												                	Russian Federation, 							Moscow, 125315						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					